Jonathan Colon

Jonathan Colon, Ph.D., currently serves as a Senior Scientist in Formulation and Drug Product Development at Third Harmonic Bio since June 2024. Prior experience includes a position as Scientist II in Formulation Development at Seres Therapeutics, where Jonathan designed and executed formulation and process development activities for various oral solid and liquid dosage forms. Additional roles include Scientist II positions at Assembly Biosciences and Bristol-Myers Squibb, focusing on drug product development, as well as a short tenure at Celgene. Academic experience encompasses a Ph.D. in Chemical and Biochemical Engineering from Rutgers University, where Jonathan developed advanced materials for military protection against chemical warfare agents. Prior to this, Jonathan held roles as a graduate teaching assistant and intern at Merck, contributing to pharmaceutical commercialization through process optimization and analytical chemistry.